Latest Derivatives News

CDC Data Centres has landed Australia's largest-ever data centre contract, a 555MW deal with a US investment grade client that pushes its total contracted capacity beyond 1GW and is set to boost EBITDAF past A$1 billion in FY28.

Entropy Neurodynamics has bolstered its intellectual property portfolio with a new US provisional patent application for TRP-8803, following compelling Phase 2a data showing a 75% response rate in treatment-resistant IBS patients.

PYC Therapeutics presented Phase 1/2 data at ARVO 2026 showing encouraging safety and efficacy signals for its RNA therapies targeting rare genetic eye diseases Retinitis Pigmentosa type 11 and Autosomal Dominant Optic Atrophy.

VanEck Investments Limited has released a comprehensive replacement Product Disclosure Statement for seven Australian bond ETFs, updating key details on investment strategies, risks, fees, and regulatory frameworks.

Pure Resources has partnered with Oak Ridge National Laboratory to develop a rare earth extraction process from its Garnet Hills garnet, aiming to add critical minerals value alongside its industrial minerals business.

Noxopharm’s SOF-16 active ingredient demonstrated potent anti-inflammatory activity in patient-derived samples of systemic lupus erythematosus and rheumatoid arthritis, advancing its Sofra™ platform beyond topical applications.

Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.

Gold Hydrogen is poised to begin flow testing at its Ramsay Project, targeting separate Natural Hydrogen and Helium zones, while advancing green methanol and helium commercialisation studies amid robust market demand.

Osmond Resources is progressing its Orión EU Critical Minerals Project with promising drilling results, positive mineral processing testwork, and a new partnership targeting rare earth carbonate production in Spain.

Dateline Resources is poised to release its Colosseum Gold Project Bankable Feasibility Study imminently, while expanding rare earth exploration at its new Music Valley project and bolstering its balance sheet with a $50 million placement.

Neurotech International has opened its first Phase 3 clinical site for NTI164 targeting Autism Spectrum Disorder, reported positive 90-day toxicology results, and launched a new Rett syndrome research collaboration.

Anax Metals’ updated DFS for Whim Creek reveals a 113% surge in free cash flow to A$723 million, underpinned by a decade-long mine life and rapid payback. The company’s $10 million capital raise strengthens its balance sheet following full repayment of a $3.5 million loan.